Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04960592 · ClinicalTrials.gov registry record

Epigenetic Mechanisms and Symptom Clusters Associated with Resolution of Pain Following Spinal Cord Stimulation

A clinical trial, sponsored by University of Arkansas.

Completed
Registry status
61
Enrollment target

NCT04960592 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 61 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04960592 has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
61 participants
Enrollment target

Study Summary

Spinal cord stimulation (SCS) is indicated for selected patients with chronic pain who have not responded to conventional medical management. Forty (40) patients indicated for SCS placement and presenting to the University of Arkansas for Medical Sciences (UAMS) Interventional Pain Management Clinic in Little Rock, Arkansas will be recruited for this study. Prior to temporary stimulator placement, patients will complete symptom-related questionnaires and provide a blood sample. Demographic and clinical characteristics will be obtained through medical record review. Patients will complete the same questionnaires and provide a blood sample at each of the routine clinical care follow-up visits.

Interventions

  • DEVICE Spinal Cord Stimulation

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2021-02-15
Est. Completion 2024-07-01

Sponsor

University of Arkansas

318 total trials

What the Registry Record Tells You About NCT04960592

The ClinicalTrials.gov registry entry for NCT04960592 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Spinal Cord Stimulation is the first listed.

NCT04960592 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04960592 about?

NCT04960592 is a clinical study titled "Epigenetic Mechanisms and Symptom Clusters Associated with Resolution of Pain Following Spinal Cord Stimulation". Spinal cord stimulation (SCS) is indicated for selected patients with chronic pain who have not responded to conventional medical management. Forty (40) patients indicated for SCS placement and presenting to the University of Arkansas for Medical Sciences (UAMS) Interventional Pain Management Clini...

What is the current status of trial NCT04960592?

This trial is currently completed. The enrollment target is 61 participants. The study started on 2021-02-15. Estimated completion is 2024-07-01.

What interventions are being tested in trial NCT04960592?

The interventions under investigation include: Spinal Cord Stimulation (DEVICE).

Who is sponsoring clinical trial NCT04960592?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.